"Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
海角七号
发表于 3 天前
124
0
0
On June 27th, it was reported in the market that the "weight loss miracle drug" Wegovy (Chinese product name: Nuoheying) will be sold in limited quantities in China. On June 28th, relevant personnel from Novo Nordisk China responded to China Securities Journal and China Securities Taurus reporter that since the approval of Novo Nordisk, the company has officially launched the relevant process of drug supply according to the plan, and will bring this heavyweight product into the Chinese market as soon as possible to benefit obese patients.
Nordisk China stated that there is a significant unmet medical demand in the field of obesity treatment. As Novo Nordisk serves an increasing number of patients, the company's GLP-1 injection product portfolio is facing huge market demand. In China, the company will adhere to the principle of being responsible to patients and supply Nuoheying in a carefully planned manner after going public to ensure the continuity of patient medication, that is, to ensure that patients who have already started treatment can continue to receive treatment.
Currently, Novartis has been listed in over 10 countries worldwide. To meet the needs of patients, the company is working hard to increase the supply of GLP-1 class drugs. The company will responsibly distribute existing product supplies in the global market, adhere to consistent standards, and focus on ensuring the continuity of patient medication and the accessibility of innovative drugs.
On June 25th, the National Medical Products Administration of China approved the marketing application of Novo Nordisk's research and production of Novo Nordisk's Novo Nordisk (Smegglutide Injection for long-term weight management) in China. It is reported that Nuoheying can achieve an average weight loss of 17% (16.8KG) and bring multiple health benefits to patients beyond weight loss, and its safety has been widely verified.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- American pharmaceutical company Anjin's weight loss pills have attracted attention, and Novo Nordisk's stock price has fallen by 5%
- Earning too much! US Senators indirectly pressure Novo Nordisk to lower the price of weight loss pills
- Novo Nordisk's "miracle weight loss medicine" new research: Not losing weight can also reduce the risk of heart disease
- Is Novo Nord Wegovy really that divine? New research will test whether it can treat alcoholic liver disease
- What is the research and development direction of weight loss drugs for Novo Nordisk after the entry of multiple giants
- The GLP-1 theme fund in the US stock market triggers thinking. Who will be the next "Novo Nordisk"?
- Novo Nordisk responds that semaglutide may cause male impotence
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- Will the reduced weight version of Smegglutide be limited in supply to the Chinese market? Novo Nordisk responds
-
理想自動車官博によると、2024年6月、理想自動車が新車47774台を納入し、前年同期比46.7%増となった。2024年第2四半期に108,581台が納入され、前年同期比25.5%増加した。2024年6月30日現在、理想自動車の累計納入台 ...
- 寒郁轩良
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
【スタンダード500指数が今年31回の高値を迎えるにあたり、ゴールドマン・サックスは今こそ「ブレーキを踏む」ことができると警告した!】今年、大手科学技術株がスタンダード500指数の強力な反発を後押しし、一連 ...
- 愿为素心人
- 前天 13:02
- 支持
- 反对
- 回复
- 收藏
-
最新の財報は市場予想を下回り、ナイキは急落した。 現地時間6月28日金曜日、米株3大株価指数が集団で下落した。終値まで、ダウ平均は0.12%、ナ指は0.71%、スタンダード500指数は0.41%下落した。 経済データについ ...
- hecgdge4
- 前天 09:48
- 支持
- 反对
- 回复
- 收藏
-
6月30日、Kindle中国電子書店はダウンロードサービスを停止し、ホット検索に突入した。 アマゾンの中国公式サイトによると、2024年6月30日からKindle中国電子書店はクラウドダウンロードサービスを停止し、その後ダ ...
- 什么大师特
- 13 小时前
- 支持
- 反对
- 回复
- 收藏